IMMEDICA PHARMA US INC. (IL)
Registration and award facts
SAM.gov registration as of
- Net obligations since FY2020
- $33.66M
- $33,656,933under this UEI
- FY2026 obligations
- $0†
- Provisional
- Awards and orders
- 1
- with positive net obligations2 IDV vehicles held
- Latest action
- Oct 7, 2026
- SAM.gov registration
- Active
- Registration expiration date Mar 13, 2027
Registration
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Business start date
- Aug 14, 2003 (23 years)
- Location
- Chicago, IL
- State of incorporation
- Delaware
- Purpose of registration
- All Awards
- Website
- marinuspharma.com
† FY2026 obligations (provisional; DoD awards signed after Jul 26, 2026 are not yet public).
Source: SAM.gov entity registration and FPDS contract actions recorded under UEI MS6UM2NBDW91. GovChime does not check exclusions.
Performance
Net obligations recorded under this UEI since FY2020. Top lists show the largest five by share of this vendor's net obligations; the shares do not sum to 100%.
Net obligations by fiscal year of action
- FY2022: $12,318,053
- FY2020: $21,338,880
Total across 2 fiscal years: $33,656,933
Top awarding agencies
- Department of Health and Human Services$33,656,933, 100%
Top awarding sub-agencies
- Office of Assistant Secretary for Preparedness and Response$33,656,933, 100%
Top NAICS by obligations
- 325412Pharmaceutical preparation manufacturing$33,656,933, 100%
Top product and service codes by obligations
- 6505Drugs and biologicals$33,656,933, 100%
Capabilities
NAICS codes
- 325412Pharmaceutical Preparation Manufacturing(primary)Small
Small: small business for that NAICS, self-certified in SAM.gov registration.
SBA certifications
No certification in the SBA profile data.
Federal Capability Statement
Marinus is dedicated to improving treatment outcomes for patients with rare epilepsies and seizure disorders. Our lead drug candidate is designed to exhibit anti-epileptic activity by virtue of its GABAA receptor modulating properties and is being developed in intravenous (IV) and oral formulations intended to maximize therapeutic reach to adult and pediatric patient populations in both acute and chronic care settings.
Capabilities & Services
Contracts
Latest awards and orders
- 36F79724D0030Federal supply schedule (FSS)VehicleDepartment of Veterans AffairsLatest action
- 75A50120C00159Definitive contractDepartment of Health and Human ServicesOffice of Assistant Secretary for Preparedness and ResponseLatest action
- 36F79723D019EFederal supply schedule (FSS)VehicleDepartment of Veterans AffairsLatest action
Contact Info
As of . Source: SAM.gov Points of Contact.
SAM.gov registration for IMMEDICA PHARMA US INC. lists a physical address and a separate mailing address, along with 2 verified points of contact. Past Performance contacts are the recommended outreach channel for due-diligence references; Government Business contacts handle procurement-facing correspondence.
Source: SAM.gov entity registration. Contacts displaying numeric or placeholder names have been filtered (defense-in-depth).
Physical Address
400 N Aberdeen St # 959
Chicago, IL, 60642
USA
Mailing Address
400 N Aberdeen St # 959
Chicago, IL, 60642
USA
Government Business Contact
Kyle Gleason
Director of Business Operations
400 N. Aberdeen Street, Suite 959
(c/o Portal Innovations)
Chicago, IL, 60642
USA
Electronic Business Contact
Joseph Auci
VP, Market Access
1755 N. Brown Road
Suite 200
Lawrenceville, GA, 30043
USA
Additional Details
As of . Source: SAM.gov Entity Registration.
IMMEDICA PHARMA US INC. has no active federal suspension or debarment on record in SAM.gov. Current SAM.gov registration expires March 13, 2027.
Source: SAM.gov entity registration (FAR responses, registration status). Always verify active exclusions against the authoritative record on SAM.gov before contract award.
Compliance & Risk Assessment
Source: SAM.gov FAR responsesSuspension/Debarment Status
SAM.gov registration reports no active exclusion
Public Display
Entity information is publicly displayed
Disaster Relief Registry
Not registered for disaster relief
Bonding Information
No bonding information provided
EDI
Not declared in SAM.gov
Business Structure
Source: SAM.govRegistration Details
Source: SAM.govInitial Registration
Last Update
Registration Activation
Fiscal Year End
Country of Incorporation
Congressional District
Other contractors in Illinois with primary NAICS 325412
- Baxter Healthcare CorporationDeerfield, IL
- Medi-Physics, Inc.Arlington Heights, IL
- GE Healthcare IncArlington Heights, IL
- Sagent Pharmaceuticals, IncSchaumburg, IL
- A-S Medication Solutions LLCLibertyville, IL
- Altathera Pharmaceuticals LLCChicago, IL